- Home
- Publications
- Publication Search
- Publication Details
Title
Stathmin 1 in normal and malignant hematopoiesis
Authors
Keywords
-
Journal
BMB Reports
Volume 47, Issue 12, Pages 660-665
Publisher
Korean Society for Biochemistry and Molecular Biology - BMB Reports
Online
2015-01-22
DOI
10.5483/bmbrep.2014.47.12.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups
- (2013) Teresa Marafioti et al. HISTOPATHOLOGY
- Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells
- (2013) João Agostinho Machado-Neto et al. LEUKEMIA RESEARCH
- The impact of CDK inhibition in human malignancies associated with pronounced defects in apoptosis: advantages of multi-targeting small molecules
- (2012) Józefa Węsierska-Gądek et al. Future Medicinal Chemistry
- Marked upregulation of Survivin and Aurora-B kinase is associated with disease progression in the myelodysplastic syndromes
- (2012) A. Yoshida et al. HAEMATOLOGICA
- Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet production
- (2011) C. Iancu-Rubin et al. BLOOD
- The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia
- (2011) R. Polak et al. BLOOD
- The potential role of Aurora kinase inhibitors in haematological malignancies
- (2011) Sherif S. Farag BRITISH JOURNAL OF HAEMATOLOGY
- Promotion of Apoptosis in Cancer Cells by Selective Purine-Derived Pharmacological CDK Inhibitors: One Outcome, Many Mechanisms
- (2011) Jozefa Wasierska-Gadek et al. CURRENT PHARMACEUTICAL DESIGN
- In vivo Safety and Antitumor Efficacy of Bifunctional Small Hairpin RNAs Specific for the Human Stathmin 1 Oncoprotein
- (2011) Anagha P. Phadke et al. DNA AND CELL BIOLOGY
- Stathmin: a protein with many tasks. New biomarker and potential target in cancer
- (2011) Barbara Belletti et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis
- (2010) Alberto M. Martelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells
- (2010) Xianping Shi et al. CANCER BIOLOGY & THERAPY
- Upregulated Op18/stathmin activity causes chromosomal instability through a mechanism that evades the spindle assembly checkpoint
- (2010) Per Holmfeldt et al. EXPERIMENTAL CELL RESEARCH
- Stathmin 1: a novel therapeutic target for anticancer activity
- (2008) Shushan Rana et al. Expert Review of Anticancer Therapy
- Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome
- (2008) Olivier Decaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease
- (2008) H. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now